Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now? The Prediction: Artificial Intelligence Will Lead to Higher Returns With Biotech Stocks. Ginkgo Bioworks Holdings (DNA) ; Average Vol. (3m): 1,, ; 1-Year Change: % ; Fair Value. Unlock ; Fair Value Upside. Unlock ; Industry. Biotechnology &. Ginkgo Bioworks Holdings NYSE:DNA Stock Report ; Last Price. US$ ; Market Cap. US$m ; 7D. % ; 1Y. % ; Updated. 26 Aug, Ginkgo Bioworks Announces Participation in William Blair's 42nd Annual Growth Stock Ginkgo Bioworks Unveils Next Generation Organism Foundry to Bring Biotech. Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. End of Day Stock Quote.
Compared to the opening price on Thursday 08/22/ on BTT of $, this is a drop of %. Ginkgo Bioworks Holdings Inc Registered Shs -A's market. Ginkgo Bioworks Holdings (NYSE:DNA) is a biotechnology company that offers a platform for cell programming that enables the biological production of various. Exchange. NYSE ; Sector. Health Care ; Industry. Biotechnology: Biological Products (No Diagnostic Substances) ; 1 Year Target. $ ; Today's High/Low. $/$ Ginkgo Bioworks Holdings Inc. Class A (DNA) Stock Performance ; BSE Sensex. , , , ; S&P Small-Cap · , , , News for Ginkgo Bioworks Holdings Stock (DNA) ; Why the Market Dipped But Ginkgo Bioworks Holdings, Inc. (DNA) Gained Today · 07/24/24 ; SHAREHOLDER ALERT: Purcell. Headquartered in Boston, Ginkgo Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to. Real time Ginkgo Bioworks (DNA) stock price quote, stock graph, news & analysis. Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets. Find the latest Ginkgo Bioworks Holdings, Inc. (DNA) stock quote, history, news and other vital information to help you with your stock trading and. Ginkgo Bioworks Holdings Inc. ; Current Ratio, ; Quick Ratio, ; Cash Ratio, ; Gross Margin, % ; Operating Margin, %. (NYSE: DNA) Ginkgo Bioworks Holdings currently has 55,, outstanding shares. With Ginkgo Bioworks Holdings stock trading at $ per share, the total.
Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from. DNA | Complete Ginkgo Bioworks Holdings Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Ginkgo Bioworks Holdings lowest stock price was $ and its highest was $ in the past 12 months. What is Ginkgo Bioworks Holdings's market cap? What is Ginkgo Bioworks Holdings Inc(DNA)'s stock price today? The current price of DNA is $ The 52 week high of DNA is $ and 52 week low is $ Get the latest Ginkgo Bioworks Holdings Inc (DNA) real-time quote, historical performance, charts, and other financial information to help you make more. This innovative biotechnology company hopes to turn things around. Keith Speights and Adria Cimino Once upon a time, Ginkgo Bioworks (NYSE:DNA) was viewed by. Real-time Price Updates for Ginkgo Bioworks Hldgs Inc (DNA-N), along with buy or sell indicators, analysis, charts, historical performance, news and more. Key statistics. On Monday, Ginkgo Bioworks Holdings Inc (DNA:NYQ) closed at , % above its week low of , set on Aug 20, I'm still pissed that they thought themselves worthy of the DNA stock symbol. I've followed Ginkgo for more than a decade. They are (and always.
Ginkgo Bioworks Holdings (DNA) · Premarket PM ET 08/23/ $ %. Previous Close · $ · ; % · Volume: 0 · Volume % Chg: % · Get a. Ginkgo Bioworks DNA:NYSE ; Close. quote price arrow down (%) ; Volume. 1,, ; 52 week range. - Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from. Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets. Ginkgo Bioworks Holdings Class A trades on the NYSE stock market under the symbol DNA. What is Ginkgo Bioworks Holdings Class A stock price doing today? As of.
End-to-End Capabilities. Unparalleled Scale. Explore Ginkgo's capabilities for therapeutics and vaccines, agriculture, nutrition and wellness, and more. As of today, Ginkgo Bioworks market cap is M. What is Ginkgo Bioworks Earnings Per Share? The Ginkgo Bioworks EPS is I'm still pissed that they thought themselves worthy of the DNA stock symbol. I've followed Ginkgo for more than a decade. They are (and always. This innovative biotechnology company hopes to turn things around. Keith Speights and Adria Cimino Once upon a time, Ginkgo Bioworks (NYSE:DNA) was viewed by. (NYSE: DNA) Ginkgo Bioworks Holdings currently has 55,, outstanding shares. With Ginkgo Bioworks Holdings stock trading at $ per share, the total. Ginkgo Bioworks Holdings (NYSE:DNA) is a biotechnology company that offers a platform for cell programming that enables the biological production of various. Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets. Ginkgo Bioworks Holdings Inc (DNA:NYQ) set a new week low during today's trading session when it reached Over this period, the share price is down -. Ginkgo Bioworks Holdings Inc. Class A (DNA) Stock Performance ; BSE Sensex. , , , ; S&P Small-Cap · , , , Get the latest Ginkgo Bioworks Holdings Inc (DNA) real-time quote, historical performance, charts, and other financial information to help you make more. News for Ginkgo Bioworks Holdings Stock (DNA) ; Why the Market Dipped But Ginkgo Bioworks Holdings, Inc. (DNA) Gained Today · 07/24/24 ; SHAREHOLDER ALERT: Purcell. Ginkgo Bioworks Announces Participation in William Blair's 42nd Annual Growth Stock Ginkgo Bioworks Unveils Next Generation Organism Foundry to Bring Biotech. Ginkgo Bioworks Holdings NYSE:DNA Stock Report ; Last Price. US$ ; Market Cap. US$m ; 7D. % ; 1Y. % ; Updated. 26 Aug, The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $ billion in It raised $ million. Ginkgo Bioworks Holdings (DNA) · Premarket PM ET 08/23/ $ %. Previous Close · $ · ; % · Volume: 0 · Volume % Chg: % · Get a. More programs = more overhead costs, more labor costs, more R&D costs. Doing business in biotech is expensive. Ginkgo had a revenue decrease of. Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now? The Prediction: Artificial Intelligence Will Lead to Higher Returns With Biotech Stocks. Ginkgo Bioworks Holdings Inc. ; Current Ratio, ; Quick Ratio, ; Cash Ratio, ; Gross Margin, % ; Operating Margin, %. Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. End of Day Stock Quote. Exchange. NYSE ; Sector. Health Care ; Industry. Biotechnology: Biological Products (No Diagnostic Substances) ; 1 Year Target. $ ; Today's High/Low. $/$. Ginkgo Bioworks DNA:NYSE ; Open ; Day High ; Day Low ; Prev Close ; 52 Week High
What Is A Good Spy App For Android | Karisma Hotels Travel Agent Rates